aTyr Pharma Investor Relations Material
Latest events
Q4 2023
aTyr Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from aTyr Pharma Inc
Access all reports
aTyr Pharma Inc. is a biotherapeutics company focused on the discovery and development of innovative medicines based on extracellular proteins to treat rare immune, inflammatory, and fibrotic diseases. The company's research is centered around the therapeutic potential of tRNA synthetase biology. aTyr's lead clinical program targets lung diseases with unmet medical needs, particularly those related to inflammation and fibrosis. The company aims to advance novel treatments that address the underlying causes of these conditions. The company is headquartered in San Diego, California, USA, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ATYR
Country
πΊπΈ United States